7 days How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

The mean of analysts’ price targets for Ionis Pharmaceuticals (IONS) points to a 55.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Pharmaceuticals · Wall Street

7 days How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

42 mins Wall Street Breakfast Podcast: Merger Buzz Powers Nissan, Honda Seeking Alpha

50 mins Top analyst revisits Nvidia stock price target after correction slump TheStreet

14 hours Heico (HEI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks

14 hours Occidental Petroleum: Why I Agree With Wall Street Seeking Alpha

15 hours Wall Street ends lower, oil dips as Fed looms Investing.com

16 hours Wall Street Lunch: Quantum Stocks Manic Seeking Alpha

16 hours Wall Street retreats, oil dips as Fed looms Investing.com

17 hours Fed Meeting Preview: This Cut May Be The Last; Shades Of 1996 For The S&P 500? Investor's Business Daily

17 hours Top Cheap Stocks Under $10 to Buy for Big Gains in 2025 Zacks

17 hours Wall St falls as Fed decision looms Investing.com

17 hours Remember to keep your head as ‘Trumphoria’ grips Wall Street MarketWatch

18 hours The Most-Searched Dividend Stocks of 2024 24/7 Wall St.

18 hours Wall St falls on caution over Fed decision after strong retail sales Investing.com

19 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

20 hours NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

21 hours Wall Street follows European stocks lower as Fed looms Investing.com

21 hours 4 Value Stocks to Buy as Wall Street Awaits Fed’s Rate Decision Zacks

21 hours One popular Wall Street indicator flashes stock-market sell signal MarketWatch

21 hours 3 Large-Cap Value Funds to Buy as Volatility Returns to Markets Zacks

22 hours 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

22 hours Wall Street Analysts Predict a 29.16% Upside in Intuitive Machines, Inc. (LUNR): Here’s What You Should Know Zacks

22 hours Wall Street Analysts See a 25.31% Upside in MKS Instruments (MKSI): Can the Stock Really Move This High? Zacks

22 hours Wall Street Analysts See a 26.76% Upside in Abercrombie (ANF): Can the Stock Really Move This High? Zacks

22 hours Wall Street opens lower after retail sales data; Fed awaited Investing.com

22 hours After Plunging -18.82% in 4 Weeks, Here’s Why the Trend Might Reverse for Braskem (BAK) Zacks

22 hours Down -17.68% in 4 Weeks, Here’s Why You Should You Buy the Dip in Euroseas (ESEA) Zacks

22 hours After Plunging -9.1% in 4 Weeks, Here’s Why the Trend Might Reverse for L3Harris (LHX) Zacks

22 hours Down -43.14% in 4 Weeks, Here’s Why Lineage Cell (LCTX) Looks Ripe for a Turnaround Zacks

22 hours Here’s Why Otter Tail (OTTR) is Poised for a Turnaround After Losing -5.26% in 4 Weeks Zacks

22 hours Is AGNC Investment (AGNC) a Buy as Wall Street Analysts Look Optimistic? Zacks

22 hours Wall Street Analysts Think Axon (AXON) Is a Good Investment: Is It? Zacks

22 hours Is It Worth Investing in SoundHound AI (SOUN) Based on Wall Street’s Bullish Views? Zacks

22 hours Brokers Suggest Investing in Cadence (CDNS): Read This Before Placing a Bet Zacks

22 hours Is Datadog (DDOG) a Buy as Wall Street Analysts Look Optimistic? Zacks

22 hours Is Carnival (CCL) a Buy as Wall Street Analysts Look Optimistic? Zacks

22 hours Wall Street Analysts Think JD.com (JD) Is a Good Investment: Is It? Zacks

22 hours Is MoneyLion (ML) a Buy as Wall Street Analysts Look Optimistic? Zacks

22 hours Brokers Suggest Investing in MercadoLibre (MELI): Read This Before Placing a Bet Zacks

22 hours Wall Street set for lower open after retail sales data, with Fed in focus Investing.com

22 hours Stock Market News for Dec 17, 2024 Zacks

22 hours Seeking Clues to Winnebago (WGO) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics Zacks

23 hours Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

23 hours Despite Fast-paced Momentum, REV Group (REVG) Is Still a Bargain Stock Zacks

23 hours Despite Fast-paced Momentum, ScanSource (SCSC) Is Still a Bargain Stock Zacks

23 hours Here Is Why Bargain Hunters Would Love Fast-paced Mover Cardlytics (CDLX) Zacks

23 hours Retail sales surge tests bets on more Fed rate cuts in 2025 TheStreet

23 hours November retail sales top Wall Street’s expectations Yahoo Finance

23 hours Amazon Faces Powerful Competition 24/7 Wall St.

24 hours Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

24 hours Bracing for a Fed Pullback on Interest Rates The New York Times

The Stock Market News